Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact.
about
Improving systemic breast cancer therapy: time to look beyond the primary tumour?Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family.Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Latest biopsy approach for suspected metastases in patients with breast cancer.Advances in the approach to novel drug clinical development for breast cancer.Molecular Concordance Between Primary Breast Cancer and Matched Metastases.Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site.N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imagingEfficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.Ki67 targeted strategies for cancer therapy.Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials.Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.Epigenetic variations in breast cancer progression to lymph node metastasis.Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
P2860
Q28078275-CC77BB88-5D1E-4A3C-BE59-3FA13A85E3C6Q33699614-D1BFB443-E8DE-4192-91BA-5D3113FC459DQ35162764-979379CD-C7D0-4003-B2F5-2308D0032AAAQ35231845-E64423A9-0FFF-4812-8AAA-EBAFEDCAB211Q35949311-F53262B7-E5D6-4241-B434-26EE5EBF6120Q37316607-2768B955-7601-42FA-B739-6216C66D1748Q38097525-FC9116FE-DB25-4EDC-8555-2CEF8081E98BQ38154494-120244FE-4D76-42B6-B94A-7715CBD6BC5EQ38206546-639F2864-1CEA-4015-8012-523885F8F842Q38810954-AEF214AE-14A2-45DE-9D92-77E8FF84BDE1Q41281294-9D31179A-E41D-480E-BC8E-94DDCCE8907FQ41347430-FE50B53F-33F2-4939-BE6B-97CA0741327BQ41716164-CE346C9C-CD84-46C9-9EE0-C2E4A5194863Q42088739-766842F6-4A12-4B69-A1A0-0396C80638E4Q45873470-2C7AF82F-8A88-4684-AB31-468FD27ECCF3Q47132011-7B18CA95-4BA9-48E5-81F3-B5763FB79027Q47994905-DE50A057-FAF0-4987-85C7-252C8799A5BEQ50655660-396B91AD-5C86-43CF-8B21-EC2308986B7AQ53633720-339D8533-0629-4DE2-9209-68EEA8CA2609Q58787276-0007B928-ADD4-484F-B0F1-160F78A8DD76
P2860
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hormonal receptor, human epide ...... d metastases: clinical impact.
@en
Hormonal receptor, human epide ...... d metastases: clinical impact.
@nl
type
label
Hormonal receptor, human epide ...... d metastases: clinical impact.
@en
Hormonal receptor, human epide ...... d metastases: clinical impact.
@nl
prefLabel
Hormonal receptor, human epide ...... d metastases: clinical impact.
@en
Hormonal receptor, human epide ...... d metastases: clinical impact.
@nl
P2093
P2860
P50
P356
P1433
P1476
Hormonal receptor, human epide ...... d metastases: clinical impact.
@en
P2093
Dino Amadori
Laura Medri
Luigi Serra
Marianna Ricci
P2860
P304
P356
10.1159/000345795
P577
2012-12-19T00:00:00Z